To evaluate if Twist1 contributes to the invasiveness in the context of NPM-Estrogen Receptor Pathway ALK expression, we initial conducted an in-vitro invasiveness assay making use of Jurkat cells that were transfected with an empty vector, NPM-ALK, or its tyrosine kinase-useless mutant, CANNABINOID RECEPTOR.
